MN1 overexpression is an important step in the development of inv(16) AML

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Leukemia

• Publication date

  2007-08-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/sj.leu.2404778PMID 17525718
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The ETS factor TEL2 is a hematopoietic oncoprotein.

  2006cited by this paper
• Cbfβ-SMMHC induces distinct abnormal myeloid progenitors able to develop acute myeloid leukemia

  2006cited by this paper
• Cbf beta-SMMHC induces distinct abnormal myeloid progenitors able to develop acute myeloid leukemia.

  2006cited by this paper
• High meningioma 1 (MN1) expression as a predictor for poor outcome in acute myeloid leukemia with normal cytogenetics.

  2006cited by this paper
• Targeted Disruption of the Mn1 Oncogene Results in Severe Defects in Development of Membranous Bones of the Cranial Skeleton

  2005cited by this paper
• Multiplexed tandem PCR: gene profiling from small amounts of RNA using SYBR Green detection

  2005cited by this paper
• Conditional MN1-TEL knock-in mice develop acute myeloid leukemia in conjunction with overexpression of HOXA9.

  2005cited by this paper
• Myeloid Leukemia-Associated Nucleophosmin Mutants Perturb p53-Dependent and Independent Activities of the Arf Tumor Suppressor Protein

  2005cited by this paper
• The 1,25(OH)2D3-regulated transcription factor MN1 stimulates vitamin D receptor-mediated transcription and inhibits osteoblastic cell proliferation.

  2005cited by this paper
• Plag1 and Plagl2 are oncogenes that induce acute myeloid leukemia in cooperation with Cbfb-MYH11.

  2005cited by this paper
• Somatic heterozygous mutations in ETV6 (TEL) and frequent absence of ETV6 protein in acute myeloid leukemia

  2005cited by this paper
• NPM mutations in acute myelogenous leukemia.

  2005cited by this paper
• MN1-TEL myeloid oncoprotein expressed in multipotent progenitors perturbs both myeloid and lymphoid growth and causes T-lymphoid tumors in mice.

  2005cited by this paper
• Insertional mutagenesis identifies genes that promote the immortalization of primary bone marrow progenitor cells.

  2005cited by this paper
• The Novel ETS Factor TEL2 Cooperates with Myc in B Lymphomagenesis

  2005cited by this paper
• Identification of genes that synergize with Cbfb-MYH11 in the pathogenesis of acute myeloid leukemia.

  2004cited by this paper
• Prognostically useful gene-expression profiles in acute myeloid leukemia.

  2004cited by this paper
• Gene expression profiling of pediatric acute myelogenous leukemia.

  2004cited by this paper
• Transformation of myeloid progenitors by MLL oncoproteins is dependent on Hoxa7 and Hoxa9.

  2003cited by this paper
• Upstream and downstream targets of RUNX proteins

  2003cited by this paper
• The MN1 oncoprotein synergizes with coactivators RAC3 and p300 in RAR-RXR-mediated transcription

  2003cited by this paper
• A self-enabling TGFbeta response coupled to stress signaling: Smad engages stress response factor ATF3 for Id1 repression in epithelial cells.

  2003cited by this paper
• Expression of a conditional AML1-ETO oncogene bypasses embryonic lethality and establishes a murine model of human t(8;21) acute myeloid leukemia.

  2002cited by this paper
• Inaugural Article: Defective repression of c-myc in breast cancer cells: A loss at the core of the transforming growth factor beta growth arrest program

  2001cited by this paper
• CREB-binding protein and p300: molecular integrators of hematopoietic transcription.

  2000cited by this paper
• The SRC family of nuclear receptor coactivators.

  2000cited by this paper
• A clonogenic common myeloid progenitor that gives rise to all myeloid lineages

  2000cited by this paper
• Genetic heterogeneity in acute myeloid leukemia: maximizing information flow from MuLV mutagenesis studies

  2000cited by this paper
• Two critical hits for promyelocytic leukemia.

  2000cited by this paper
• The MN1-TEL Fusion Protein, Encoded by the Translocation (12;22)(p13;q11) in Myeloid Leukemia, Is a Transcription Factor with Transforming Activity

  2000cited by this paper
• The leukemia-associated gene TEL encodes a transcription repressor which associates with SMRT and mSin3A.

  1999cited by this paper
• Both TEL and AML-1 Contribute Repression Domains to the t(12;21) Fusion Protein

  1999cited by this paper
• The fusion gene Cbfb-MYH11 blocks myeloid differentiation and predisposes mice to acute myelomonocytic leukaemia

  1999cited by this paper
• TEL Is a Sequence-specific Transcriptional Repressor*

  1999cited by this paper
• Inhibition of vascular endothelial growth factor-induced endothelial cell migration by ETS1 antisense oligonucleotides.

  1997cited by this paper
• Oncogenic transcription factors in the human acute leukemias.

  1997cited by this paper
• Disruption of the Cbfa2 gene causes necrosis and hemorrhaging in the central nervous system and blocks definitive hematopoiesis.

  1996cited by this paper
• Core binding factor beta-smooth muscle myosin heavy chain chimeric protein involved in acute myeloid leukemia forms unusual nuclear rod-like structures in transformed NIH 3T3 cells.

  1996cited by this paper
• AML1, the target of multiple chromosomal translocations in human leukemia, is essential for normal fetal liver hematopoiesis.

  1996cited by this paper
• Failure of embryonic hematopoiesis and lethal hemorrhages in mouse embryos heterozygous for a knocked-in leukemia gene CBFB-MYH11.

  1996cited by this paper
• Absence of fetal liver hematopoiesis in mice deficient in transcriptional coactivator core binding factor beta.

  1996cited by this paper
• Molecular pathogenesis of the chromosome 16 inversion in the M4Eo subtype of acute myeloid leukemia.

  1995cited by this paper
• Cloning and characterization of MN1, a gene from chromosome 22q11, which is disrupted by a balanced translocation in a meningioma.

  1995cited by this paper
• Fusion of PDGF receptor beta to a novel ets-like gene, tel, in chronic myelomonocytic leukemia with t(5;12) chromosomal translocation.

  1994cited by this paper
• Establishment and characterization of a new human leukemia cell line derived from M4E0.

  1991cited by this paper
• Proposal for the recognition of minimally differentiated acute myeloid leukaemia (AML‐MO)

  1991cited by this paper
• A t(4;22) in a meningioma points to the localization of a putative tumor-suppressor gene.

  1991cited by this paper

• Elucidating the risk factors and oncogene drivers of acute myeloid leukemia

  2025cites this paper
• Clonal evolution of the 3D chromatin landscape in patients with relapsed pediatric B-cell acute lymphoblastic leukemia

  2024cites this paper
• Refinement of Risk-Stratification of Cytogenetically Normal Acute Myeloid Leukemia Adult Patients by MN1 Expression

  2024cites this paper
• METTL14-mediated epitranscriptome modification of MN1 mRNA promote tumorigenicity and all-trans-retinoic acid resistance in osteosarcoma

  2022cites this paper
• Menin is necessary for long term maintenance of meningioma-1 driven leukemia

  2021cites this paper
• A concise review on the molecular genetics of acute myeloid leukemia.

  2021cites this paper
• MN1, FOXP1 and hsa-miR-181a-5p as prognostic markers in acute myeloid leukemia patients treated with intensive induction chemotherapy and autologous stem cell transplantation.

  2020cites this paper
• Prognostic significance of combined BAALC and MN1 gene expression level in acute myeloid leukemia with normal karyotype

  2020cites this paper
• Is There a Genetic Relationship between Acute Lymphoblastic Leukemia and Meningioma? A Case Report of the Analyses of Three Genes

  2020cites this paper
• The clinical mutatome of core binding factor leukemia

  2020cites this paper
• DNA Methylation Clusters and Their Relation to Cytogenetic Features in Pediatric AML

  2020cites this paper
• Effective drug treatment identified by in vivo screening in a transplantable patient-derived xenograft model of chronic myelomonocytic leukemia

  2020cites this paper
• Role of Meningioma 1 for maintaining the transformed state in MLL-rearranged acute myeloid leukemia: potential for therapeutic intervention?

  2020cites this paper
• Ectopia associated MN1 fusions and aberrant activation in myeloid neoplasms with t(12;22)(p13;q12)

  2020influential citation
• Analysis of genetic variation contributing to measured speed in Thoroughbreds identifies genomic regions involved in the transcriptional response to exercise.

  2019cites this paper
• Prognostic Impact of Blood MN1 Copy Numbers Before Allogeneic Stem Cell Transplantation in Patients With Acute Myeloid Leukemia

  2019cites this paper
• High expression of meningioma 1 is correlated with reduced survival rates in colorectal cancer patients.

  2019cites this paper
• Novel strategy for rapid functional in vivo validation of oncogenic drivers in haematological malignancies

  2019cites this paper
• Isoform-specific involvement of Brpf1 in expansion of adult hematopoietic stem and progenitor cells

  2019cites this paper
• MN1 C-terminal truncation syndrome is a novel neurodevelopmental and craniofacial disorder with partial rhombencephalosynapsis.

  2019cites this paper
• Meningioma 1 is indispensable for mixed lineage leukemia-rearranged acute myeloid leukemia

  2019cites this paper
• Refining statistics clarifies leukaemic stem cell genomics

  2018cites this paper
• MN1 overexpression is driven by loss of DNMT3B methylation activity in inv(16) pediatric AML

  2018cites this paper
• Myeloid neoplasms with t(12;22)(p13;q12)/MN1-EVT6: a systematic review of 12 cases

  2018cites this paper
• Genome-wide association analysis identifies SNPs predictive of in vitro leukemic cell sensitivity to cytarabine in pediatric AML

  2018cites this paper
• Meis2 as a critical player in MN1-induced leukemia

  2017cites this paper
• The Meningioma 1 (MN1) Gene is an Independent Poor Prognostic Factor in Adult Egyptian Acute Myeloid Leukemia Patients

  2017cites this paper
• MN1 and PTEN gene expression in acute myeloid leukemia

  2017cites this paper
• DEK protein level is a biomarker of CD138positive normal and malignant plasma cells

  2017cites this paper
• Targeting binding partners of the CBFβ-SMMHC fusion protein for the treatment of inversion 16 acute myeloid leukemia

  2016cites this paper
• Cancer stem cells: lessons learned from the leukemic stem cells

  2016cites this paper
• MLL1 and DOT1L cooperate with meningioma-1 to induce acute myeloid leukemia.

  2016influential citation
• Variable but consistent pattern of Meningioma 1 gene (MN1) expression in different genetic subsets of acute myelogenous leukaemia and its potential use as a marker for minimal residual disease detection

  2016cites this paper
• High MN1 expression increases the in vitro clonogenic activity of primary mouse B-cells.

  2015cites this paper
• Mouse models for core binding factor leukemia

  2015cites this paper
• CBFB-MYH11 hypomethylation signature and PBX3 differential methylation revealed by targeted bisulfite sequencing in patients with acute myeloid leukemia

  2014cites this paper
• Impacto de las alteraciones moleculares en el pronóstico de la Leucemia Mieloide Aguda (LMA) "de novo"

  2014cites this paper
• Cell Fate Decisions in Malignant Hematopoiesis: Leukemia Phenotype Is Determined by Distinct Functional Domains of the MN1 Oncogene

  2014cites this paper
• Gene Therapy for Wiskott-Aldrich Syndrome—Long-Term Efficacy and Genotoxicity

  2014cites this paper
• Constitutive IRF8 expression inhibits AML by activation of repressed immune response signaling

  2014cites this paper
• MicroRNA in Leukemias

  2013cites this paper
• The clinical characteristics and prognostic significance of MN1 gene and MN1-associated microRNA expression in adult patients with de novo acute myeloid leukemia

  2013cites this paper
• Core binding factor acute myeloid leukemia: the impact of age, leukocyte count, molecular findings, and minimal residual disease

  2013cites this paper
• Mapping of MN1 Sequences Necessary for Myeloid Transformation

  2013cites this paper
• Core-binding factor acute myeloid leukemia: can we improve on HiDAC consolidation?

  2013cites this paper
• Meningioma 1 (MN1) expression: Refined risk stratification in acute myeloid leukemia with normal cytogenetics (CN-AML)

  2013cites this paper
• Caractérisation clinique et moléculaire de nouvelles translocations chromosomiques ciblant le gène RUNX1 dans les leucémies aiguës de l’adulte

  2012cites this paper
• Overexpression of MN1 Confers Resistance to Chemotherapy, Accelerates Leukemia Onset, and Suppresses p53 and Bim Induction

  2012cites this paper
• An insertional mutagenesis screen identifies genes that cooperate with Mll-AF9 in a murine leukemogenesis model.

  2012cites this paper
• The Leukemia-Associated Fusion Protein MN1-TEL Blocks TEL-Specific Recognition Sequences

  2012cites this paper
• Molecular pathogenesis of core binding factor leukemia: current knowledge and future prospects

  2011cites this paper
• prognostic markers in childhood acute myeloid leukemia expression are independent BAALC-ITD and high FLT 3 Presence of

  2011cites this paper
• Epigenetic mechanisms in acute myeloid leukemia.

  2011cites this paper
• Presence of FLT3-ITD and high BAALC expression are independent prognostic markers in childhood acute myeloid leukemia.

  2011cites this paper
• Cell of origin in AML: susceptibility to MN1-induced transformation is regulated by the MEIS1/AbdB-like HOX protein complex.

  2011cites this paper
• A more efficient killing machine : how CpG-oligodeoxynucleotides enhance natural killer cell cytokine production and cytotoxicity against leukemia initiating cells

  2011cites this paper
• Presence of FLT 3-ITD and high BAALC expression are independent prognostic markers in childhood acute myeloid leukemia *

  2011cites this paper
• Accelerated leukemogenesis by truncated CBF beta-SMMHC defective in high-affinity binding with RUNX1.

  2010cites this paper
• Mouse Models of Myeloid Leukemia

  2010cites this paper
• Extrinsic signals determine myeloid-erythroid lineage switch in MN1 leukemia.

  2010cites this paper
• Functional characterization of high levels of meningioma 1 as collaborating oncogene in acute leukemia

  2010cites this paper
• Molecular diagnosis of acute myeloid leukemia

  2010cites this paper
• Functional role of BAALC in leukemogenesis

  2010cites this paper
• Modeling the functional heterogeneity of leukemia stem cells: role of STAT5 in leukemia stem cell self-renewal.

  2009cites this paper
• 1,25-DIHYDROXYVITAMIN D3-INDUCED GENES IN OSTEOBLASTS: UNCOVERING NEW FUNCTIONS FOR MENINGIOMA 1 AND SEMAPHORIN 3B IN SKELETAL PHYSIOLOGY

  2009cites this paper
• Molecular Analysis of the MN1 Oncogene and the Leukemia-Associated Fusion Gene MN1-TEL

  2009cites this paper
• Prognostic importance of MN1 transcript levels, and biologic insights from MN1-associated gene and microRNA expression signatures in cytogenetically normal acute myeloid leukemia: a cancer and leukemia group B study.

  2009influential citation
• Meningioma 1 gene is differentially expressed in CD34 positive cells from bone marrow of patients with myelodysplastic syndromes with the highest expression in refractory anemia with excess of blasts and secondary acute myeloid leukemia

  2009cites this paper
• Differentiation therapy of acute myeloid leukemia: past, present and future.

  2009cites this paper
• Prognostic Importance of MN 1 Transcript Levels , and Biologic Insights From MN 1-Associated Gene and MicroRNA Expression Signatures in Cytogenetically Normal Acute Myeloid Leukemia : A Cancer and Leukemia Group B Study

  2009influential citation
• Meningioma 1 Is Required for Appropriate Osteoblast Proliferation, Motility, Differentiation, and Function*

  2009cites this paper
• Identification of cooperating genetic events in acute leukemia

  2009cites this paper
• Reintroduction of CEBPA in MN1-overexpressing hematopoietic cells prevents their hyperproliferation and restores myeloid differentiation.

  2009cites this paper
• Advances in molecular genetics and treatment of core-binding factor acute myeloid leukemia

  2008cites this paper
• MN1 affects expression of genes involved in hematopoiesis and can enhance as well as inhibit RAR/RXR-induced gene expression.

  2008cites this paper
• The Mn1 transcription factor acts upstream of Tbx22 and preferentially regulates posterior palate growth in mice

  2008cites this paper
• Genetic abnormalities in acute myelogenous leukemia with normal cytogenetics

  2008cites this paper
• Gata1 regulates dendritic-cell development and survival.

  2007cites this paper
• Treating AML with ATRA? Beware MN1 !

  2007cites this paper
• MN1, a novel player in human AML.

  2007cites this paper
• Genetic Testing Methods in Myelodysplastic Syndromes and Leukemias: A Review

  2007cites this paper